Pharmaceutical Companies
Lexicon Pharmaceuticals
๐บ๐ธUnited States
- Ownership
- Public, Subsidiary
- Established
- 1995-01-01
- Employees
- 285
- Market Cap
- $621.7M
- Website
- http://www.lexpharma.com
Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include: LX9211, an orally-delivered small molecule drug...
Entrada Therapeutics
๐บ๐ธUnited States
IGM Biosciences
๐บ๐ธUnited States
IGM Biosciences, Inc. operates as a biotechnology company, which develops antibodies for the treatment of cancer. It offers the IgM platform to expand upon the inherent properties of IgM antibodies and to allow for the rapid development of...
Mineralys Therapeutics
๐บ๐ธUnited States
Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing medicines to target diseases driven by abnormally elevated aldosterone. Its clinical-stage product candidate, lorundrostat, is a...
Lexicon Therapeutics
๐บ๐ธUnited States
- Ownership
- Private
- Established
- -
- Employees
- -
- Market Cap
- $604.3M
- Website
- -
Urogen Pharma, Inc.
๐บ๐ธUnited States
- Ownership
- -
- Established
- -
- Employees
- -
- Market Cap
- $600.9M
- Website
- -
Puretech Health
๐บ๐ธUnited States
PureTech Health Plc engages in the provision of differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological...
GH Research
๐ฎ๐ชIreland
GH Research Plc operates as a holding company, which engages in the provision of biopharmaceutical products and services. It develops therapeutic products for patients of psychiatric and neurological disorders. The firm develops novel and...
DocMorris AG
๐จ๐ญSwitzerland
Regenxbio
๐บ๐ธUnited States
- Ownership
- -
- Established
- -
- Employees
- 344
- Market Cap
- $573.8M
- Website
- -